MedDataX Logo

Effect of Intraoperative Neuromuscular Blockade on Postoperative Sore Throat and Hoarseness

NCT ID: NCT03397797

Last Updated: 2019-12-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

117 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-09-01

Study Completion Date

2019-11-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Investigators assess and compare postoperative sore throat and hoarseness in the group using the muscle relaxant and not using it during the operation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The muscle relaxant is usually used during the operation to maintain moderate relaxation but, it can't be used in the surgery to need eletrophysiological monitoring during the operation. In this sturdy, the investigators assess the postoperative sore throat and hoarseness and compare the effect of muscle relaxant in the group using the muscle relaxant and not using it in terms of the incidence and severity of postoperative sore throat and hoarseness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sore Throat

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

muscle relaxant

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group with muscle relaxant

Rocuronium is used during the operation to maintain moderate relaxation.

Rocuronium

Intervention Type DRUG

In the group to need the eletrophysiological monitoring during the operation, we don't inject muscle relaxant except anestheitic induction.

Group without muscle relaxant

Rocuronium is not used during the operation for the eletrophysiological monitoring.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rocuronium

In the group to need the eletrophysiological monitoring during the operation, we don't inject muscle relaxant except anestheitic induction.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

* known or predicted difficult airway
* neuromuscular diseases
* hepatic or renal dysfunction
* diseases or anatomical abnormalities in the neck, larynx, or pharynx
* requirement for postoperative mechanical ventilation
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

SMG-SNU Boramae Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jin-Young Hwang

associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jin-Yong Hwang, M.D.,Ph. D.

Role: PRINCIPAL_INVESTIGATOR

SMG-SNU Boramae Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jee-Eun Chang

Seoul, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20170605/10-2017-6/063

Identifier Type: -

Identifier Source: org_study_id